Pfizer, Inc. (PFE) Tops Q3 EPS by 7c; Raises Buyback Target to $7-$9B; Reaffirms Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $29.82 -0.96%
EPS Growth %: -16.1%
Financial Fact:
Discontinued operations--net of tax: 0
Today's EPS Names:
OMID, BCML, CZNC, More
EPS Growth %: -16.1%
Financial Fact:
Discontinued operations--net of tax: 0
Today's EPS Names:
OMID, BCML, CZNC, More
Join SI Premium – FREE
Pfizer, Inc. (NYSE: PFE) reported Q3 EPS of $0.62, $0.07 better than the analyst estimate of $0.55. Revenue for the quarter came in at $17.2 billion versus the consensus estimate of $16.43 billion.
Raises its buyback target to $7-$9 billion.
Reaffirms FY11 guidance.
Raises its buyback target to $7-$9 billion.
Reaffirms FY11 guidance.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix shares fall over 5% premarket on soft current-quarter revenue guidance
- Elevance Health Inc. (ELV) Tops Q3 EPS by $2.29, Beats on Revenue; Offers FY EPS Guidance
- Alaska Air Group (ALK) Tops Q3 EPS by 8c; offers guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Stock BuybacksSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
